Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 10;89(1):e1-e7.
doi: 10.4102/ojvr.v89i1.1955.

Comparing the minimum inhibitory and mutant prevention concentrations of selected antibiotics against animal isolates of Pasteurella multocida and Salmonella typhimurium

Affiliations

Comparing the minimum inhibitory and mutant prevention concentrations of selected antibiotics against animal isolates of Pasteurella multocida and Salmonella typhimurium

Jeanette M Wentzel et al. Onderstepoort J Vet Res. .

Abstract

Historically, the use of antibiotics was not well regulated in veterinary medicine. The emergence of antibiotic resistance (ABR) in pathogenic bacteria in human and veterinary medicine has driven the need for greater antibiotic stewardship. The preservation of certain antibiotic classes for use exclusively in humans, especially in cases of multidrug resistance, has highlighted the need for veterinarians to reduce its use and redefine dosage regimens of antibiotics to ensure efficacy and guard against the development of ABR pathogens. The minimum inhibitory concentration (MIC), the lowest concentration of an antibiotic drug that will prevent the growth of a bacterium, is recognised as a method to assist in antibiotic dosage determination. Minimum inhibitory concentrations sometimes fail to deal with first-step mutants in bacterial populations; therefore dosing regimens based solely on MIC can lead to the development of ABR. The mutant prevention concentration (MPC) is the minimum inhibitory antibiotic concentration of the most resistant first-step mutant. Mutant prevention concentration determination as a complementary and sometimes preferable alternative to MIC determination for veterinarians when managing bacterial pathogens. The results of this study focused on livestock pathogens and antibiotics used to treat them, which had a MIC value of 0.25 µg/mL for enrofloxacin against all 27 isolates of Salmonella typhimurium. The MPC values were 0.50 µg/mL, with the exception of five isolates that had MPC values of 4.00 µg/mL. The MPC test yielded 65.52% (18 isolates) Salmonella isolates with florfenicol MICs in the sensitive range, while 11 isolates were in the resistant range. Seventeen isolates (58.62%) of Pasteurella multocida had MIC values in the susceptible range and 41.38% (12 isolates) had an intermediate MIC value. Mutant prevention concentration determinations as done in this study is effective for the antibiotic treatment of bacterial infections and minimising the development of resistance. The MPC method can be used to better control to prevent the development of antibiotic drug resistance used in animals.

Keywords: MIC; MPC; Pasteurella; Salmonella; animals; minimum inhibitory concentration; mutant prevention concentration.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

Figures

FIGURE 1
FIGURE 1
Adapted mutant prevention concentration method plate – With C being the control, the other each section an antibiotic dilution.

Similar articles

Cited by

References

    1. Blondeau, J.M., 2009a, ‘New concepts in antimicrobial susceptibility testing: The mutant prevention concentration and mutant selection window approach’, Veterinary Dermatology 20(5–6), 383–396. 10.1111/j.1365-3164.2009.00856.x - DOI - PubMed
    1. Blondeau, J.M., 2009b, STAT International companion animal: Steps to antimicrobial therapy, North American Compendiums, Incorporated, Port Huron, MI.
    1. Blondeau, J.M., Borsos, S., Hesje, C., Blondeau, L.D. & Blondeau, B.J., 2007, ‘Comparative minimum inhibitory concentration (MIC) and mutant prevention concentration (MPC) values of enrofloxacin, florfenicol, tilmicosin and tulathromycin against Mannheimia haemolytica (MH) isolates collected from cattle and bovine respiratory disease’, in International meeting of emerging diseases and surveillance (IMED), February 23–25, 2007, Vienna, Austria.
    1. Blondeau, J.M. & Fitch, S.D., 2019, ‘Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis’, PLoS One 14(1), e0210154. 10.1371/journal.pone.0210154 - DOI - PMC - PubMed
    1. Blondeau, J.M., Hansen, G., Metzler, K. & Hedlin, P., 2004, ‘The role of PK/PD parameters to avoid selection and increase of resistance: Mutant prevention concentration’, Journal of Chemotherapy 16(3), 1–19. 10.1080/1120009X.2004.11782371 - DOI - PubMed

MeSH terms

LinkOut - more resources